ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor frequently deleted in advanced prostate cancer that functions as a transcription elongation factor of RNA Pol II through interaction with the ELL family proteins. EAF2 knockout mice on a 129P2/OLA-C57BL/6J background developed late-onset lung adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma and high-grade prostatic intraepithelial neoplasia. In order to further characterize the role of EAF2 in the development of prostatic defects, the effects of EAF2 loss were compared in different murine strains. In the current study, aged EAF2-/- mice on both the C57BL/6J and FVB/NJ backgrounds exhibited mPIN lesions as previously reported on a 129P2/OLA-C57BL/6J background...
Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic...
TMEFF2 is a type I transmembrane protein with two follistatin (FS) and one EGF-like domain over-expr...
BACKGROUND Loss‐of‐function of Pax2 results in severe defects of the male reproductive system, and ...
ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor frequently deleted in adva...
<p>A. Strain-specific incidence rate of mPIN in EAF2<sup>−/−</sup> mice at age 20–24 mos compared to...
Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor genes pho...
<p>A. Incidence in prostate epithelial hyperplasia (Epi) and stromal defects (Str) in C57BL/6J EAF2<...
Prostate Cancer (PCa) is the most commonly diagnosed cancer and the second most common cause of canc...
Androgens are known to protect prostate cancer cells from DNA damage. Recent studies showed regulati...
<p>A. In situ hybridization analysis of EAF2 mRNA in murine prostate tissue. Both anti-sense (upper ...
Prostate cancer is the second leading cause of cancer-related deaths in men. Activation of MAP kinas...
Recent work with mouse models of prostate cancer (CaP) has shown that inactivation of TGFβ signaling...
Factors that drive prostate cancer progression remain poorly defined, thus hindering the development...
BACKGROUND: In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic...
Contains fulltext : 58555schalken.pdf (publisher's version ) (Closed access)OBJECT...
Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic...
TMEFF2 is a type I transmembrane protein with two follistatin (FS) and one EGF-like domain over-expr...
BACKGROUND Loss‐of‐function of Pax2 results in severe defects of the male reproductive system, and ...
ELL-associated factor 2 (EAF2) is an androgen-responsive tumor suppressor frequently deleted in adva...
<p>A. Strain-specific incidence rate of mPIN in EAF2<sup>−/−</sup> mice at age 20–24 mos compared to...
Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor genes pho...
<p>A. Incidence in prostate epithelial hyperplasia (Epi) and stromal defects (Str) in C57BL/6J EAF2<...
Prostate Cancer (PCa) is the most commonly diagnosed cancer and the second most common cause of canc...
Androgens are known to protect prostate cancer cells from DNA damage. Recent studies showed regulati...
<p>A. In situ hybridization analysis of EAF2 mRNA in murine prostate tissue. Both anti-sense (upper ...
Prostate cancer is the second leading cause of cancer-related deaths in men. Activation of MAP kinas...
Recent work with mouse models of prostate cancer (CaP) has shown that inactivation of TGFβ signaling...
Factors that drive prostate cancer progression remain poorly defined, thus hindering the development...
BACKGROUND: In prostate adenocarcinoma, the dissection of the expression behaviour of the eukaryotic...
Contains fulltext : 58555schalken.pdf (publisher's version ) (Closed access)OBJECT...
Background: U19/EAF2 is a potential tumor suppressor exhibiting frequent down-regulation and allelic...
TMEFF2 is a type I transmembrane protein with two follistatin (FS) and one EGF-like domain over-expr...
BACKGROUND Loss‐of‐function of Pax2 results in severe defects of the male reproductive system, and ...